• Q1 2021 report notes distinction of becoming first psychedelic company to list on the NYSE American LLC stock exchange
• Cybin has garnered “a great deal of attention as an emerging leader in the psychedelic therapeutics space,” says CEO
• Several of the quarter’s highlights tied into the company’s active development of its psychedelic pipeline

Cybin (NEO: CYBN) (NYSE American: CYBN) is wrapping up a highly successful first quarter with the release of its Q1 2021 operational and financial report, for the period ended June 30, 2021 (https://ibn.fm/V9xNp). The biotech company, which is focused on progressing psychedelic therapeutics, hit some milestones this quarter, including becoming the first psychedelic company to list on the NYSE American LLC stock exchange and raising more than C$120 million, including the C$34 million raised during the company’s latest equity financing round. “During the past several months, Cybin has garnered a great deal of attention as an emerging leader in the psychedelic therapeutics space,” said Cybin CEO Doug Drysdale. “We believe the molecules we have under development may have the potential to transform the treatment landscape and fill current unmet treatment needs for various psychiatric and neurological conditions. We look forward to sharing updates as we advance our pre-clinical and clinical programs and continue the scientific exploration that we believe will ultimately provide safer and more effective treatments for those suffering with mental illness and addiction issues.” Several of the quarter’s highlights tied into the company’s active development of its psychedelic pipeline. The company has started the next phase of its digital therapeutics platform designed to better enable the evaluation of patient outcomes through a highly secure, patient-centered data analytics platform for both pre- and postpsychedelic treatments. Cybin also signed an exclusive R&D collaboration agreement with TMS NeuroHealth Centers Inc., a wholly owned subsidiary of Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH), which runs 129 outpatient mental health service centers in the United States. Based on the agreement, Cybin and Greenbrook will establish Mental Health Centers of Excellence that will focus on facilitating research and development of innovative psychedelic compound-based therapeutics for patients suffering from depression. Finally, Cybin announced that is has begun scaling up its European operations and research activities with several academic and clinical research organizations; the company is also working to transfer its intellectual property assets to its recently formed, wholly owned Ireland subsidiary. The volume of Cybin’s IP is growing as well, with the company’s patent portfolio now numbering 13 filings. Those filings cover novel psychedelic compounds, integration of delivery platforms, methods of use in psychiatric indications, and drug-discovery pipeline of modified and novel ergolines, tryptamines and phenethylamines. In addition to these key operational highlights, Cybin also posted cash and cash equivalents reaching C$55.1 million for the quarter, boosting the company’s current cash position to C$82.5 million. Those funds are an invaluable resource for the company as it works to progress its clinical pipeline and achieve vital business initiatives. The company is dedicated to revolutionizing mental health care through the use of psychedelic therapeutics and proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• China-based information technology company Infobird recently launched a WeChat call center designed to incorporate WeChat’s multi-channel functionality with Infobird’s SaaS platform for recruiting and retaining customers
• Infobird’s platform uses big data and AI to create “portraits” of consumers’ expectations and needs by analyzing input from multiple channels
• WeChat became the world’s largest standalone mobile app in 2018 with over 1 billion monthly active users of its messaging, social media and mobile payment services
• Infobird’s cloud computing and AI technologies have generated more than 70 proprietary licensing rights

The growth of China’s robust economic engine and the rapid modern development of the nation’s middle and upper-middle class societies in recent years has driven both domestic and foreign companies to seek out and court the hundreds of millions of Chinese consumers connected to the economy through technological tools (https://ibn.fm/B5uv6). Companies seeking to use their resources in the most effective manner possible to acquire and retain consumers have turned to the automated, intelligent solutions big data and artificial intelligence (“AI”) can provide through the software-as-a-service (SaaS) market. Chinese SaaS innovator Infobird (NASDAQ: IFBD) is making a name for itself through its recent Nasdaq debut as well as a growing number of retail agreements that use its technology, and on July 26 the company announced its next step with the launch of its WeChat call center. The WeChat call center is designed to help businesses build an automated and personalized private domain traffic operation platform that will help the B2C clients achieve major upgrades while drawing on the the advantages of the powerful WeChat ecosystem for interacting with customers. WeChat is a Chinese multi-channel messaging, social media and mobile payment app that became the world’s largest standalone mobile app in 2018 with over 1 billion monthly active users (https://ibn.fm/n9wNn). Infobird’s WeChat call center brings the functionality of corporate WeChat to Infobird’s multi-channel customer interaction platform with “an exclusive private domain traffic ecosystem for enterprises through four steps” that include attracting customers, retaining customers, keeping customers actively engaged and successfully managing the customer service interactions of company personnel, according to the Google translation of the company’s Chinese news release (https://ibn.fm/pLmqK). Using private domain traffic for the development of long-term customer relationships has become a necessary path to company growth. The SaaS industry in China was valued at $3.3 billion last year after growing 43.5 percent from the year before (https://ibn.fm/dJT7T). Infobird has created a single platform to meet the needs of consumers and businesses by using big data and AI to analyze input from multiple channels and then generate portraits or profiles that represent each user, their expectations and their needs. The platform provides the means for companies to understand their customers more completely and accurately, which makes it possible for the companies to employ precision marketing in e-commerce and physical stores, incorporating Infobird’s product into the companies’ infrastructure in an essentially seamless manner. Infobird is focused on SMEs, demystifying software and automation in business processes. The advent of the COVID-19 pandemic last year expanded remote-work demands exponentially for businesses from small family operations to large corporations, and Internet cloud-based technology has stepped in to fill the need. For more information, visit the company’s website at www.Infobird.com/en/index.html. NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

• InnerScope has created strategic partnerships with national pharmacy chains, big-box retailers, and national and local grocery chains to tap into the global hearing aid market expected to grow from $6.47bn in 2020 to $11.02bn by 2028
• InnerScope’s launches its hearing aids on FSAstore.com, HSAstore.com, and WellDeservedHealth.com consumers enrolled in flexible spending accounts (“FSA”), health saving accounts (“HAS”), and employers’ health incentive programs
• Announced a Media Blitz consisting of 660 commercials to be aired across major networks and digital billboards over the next six months to raise awareness of increased access to hearing aids and drive traffic to the company website
• President Biden signed an executive order and made remarks regarding the need for hearing aids and products to be made more readily available and affordable to the many Americans who are currently going without

In 2020 the global hearing aid market reported a value of $6.47 billion. By 2028 the same market is expected to reach $11.02. The growth is expected due to the innovations being made by companies like InnerScope Hearing Technologies (OTC: INND). There are currently an estimated 70 million Americans who experience some form of hearing-related problem. InnerScope Hearing Technologies is a leading wholesale provider and direct-to-consumer business that has strategic partnerships with Walmart and Amazon Prime, and numerous other online and brick-and-mortar retail stores in the works. In addition, InnerScope was the first to market free self-check hearing screening kiosks and contract with national pharmacy chains, big-box retailers, and national and local grocery chains to deploy them throughout the U.S. In Addition, InnerScope recently launched its hearing aids and related hearing products on FSAstore.com, HSAstore.com, and WellDeservedHealth.com for the 70 million consumers enrolled in flexible spending accounts (“FSA”), health saving accounts (“HSA”), and employers’ health incentive programs. The company provides an extensive range of hearing-related products and services that include:

• Free hearing testing on the website
• Free HearIQ app for IOS and Android for hearing testing and allows full control of its Bluetooth hearing aids
• Self-service fully automated hearing screening kiosks
• FDA-registered Bluetooth app-controlled self-adjusting rechargeable hearing aids and personal sound amplifiers
• Doctor-formulated dietary hearing and tinnitus supplements
• Flexible subscription program that provides affordable monthly payment options to purchase hearing aids and free upgrades every two years
• Ear care and cleaning solutions

In July of 2021, InnerScope Hearing Technologies announced its launching a six-month Media Blitz with a minimum of 660 commercials being aired across major networks and on 156 digital billboards. The goal is to capture the attention of the many individuals who have hearing loss and have not had access to an audiologist. In addition, the commercials will increase awareness of the changes in access to over-the-counter (“OTC”) hearing aids and ultimately drive traffic to the company’s website. “The launch of our Hearing Loss Media Blitz Campaign could not have come at a better time,” said InnerScope Hearing Technologies’ CEO Matthew Moore (https://ibn.fm/EwNWq). The announcement of our launch came only a week after President Biden signed an executive order and made remarks on the necessity of hearing aids being made more affordable and accessible (https://ibn.fm/2sckI). For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

Simply Sonoma is a therapeutic-focused CBD company concentrating on sleep aids, gut health, pain/inflammation, as well as skin and beauty products.  The company has developed plant-based CBD infused products, centered around the agriculture of Sonoma County, California, known for its excellent wines, fruits, and veggies, and now the company aims to put it on the map for exceptional organic plant-based CBD infused, and research- backed formulations. It seems everyone is jumping on the CBD bandwagon these days, including Martha Stewart.  The market seems to be awash with companies that throw CBD up on the wall to see what sticks.  There really isn’t clear information regarding application, appropriate dosing, and efficacy.  Simply Sonoma intends to bring some clarity to the marketplace, with a focus on consumer education. The company founders of Simply Sonoma come from a long history in the healthcare industry, as well as the hospital sector.  Company executives have worked at a variety of biotechnology companies including Aviron, the company that invented the flu inoculation that is sprayed up your nose.  Principals have experience working with personal genetic therapy companies as well as arthritis and inflammation products companies. From personal experience, and the trials and tribulations of friends and family, Simply Sonoma has taken notice of the medicinal utility of CBD and cannabis.   As scientists, they were initially skeptical, but seeing firsthand family member experiences with pain relief was very convincing. Additionally, there is now a significant amount of research that has been done on the endocannabinoid system in the human body, which seems to back up the anecdotal reports. The company is currently in a SEC CF raise to build out its portfolio. Why Simply Sonoma is Different:

• They are focused on formulations, driven by Scientific research
• They consider appropriate dosing & consumer education imperative to convey
• With different ways to consume, they offer alternatives to just gummies and tinctures.
• Simply Sonoma is producing CBD infused organic apple juices, CBD infused alcohol-free Sonoma County wine grape beverages, and more.

The company wants to bring alternatives to the traditional boring gummies and tinctures.  Simply Sonoma offers alternative products that are more lifestyle focused and round out the experience with education on how to effectively use CBD on a daily basis.  For instance, they have created an exceptional, alcohol-free CBDE Pinot Noir beverage that you can order in a restaurant as an after-dinner alternative to wine, cocktails, or coffee. Imagine relaxing in the evening without the side effects of alcohol with a beverage that comes in a half wine bottle size (375 ml)! For more information, visit the company’s website at www.SimplySonoma.org. NOTE TO INVESTORS: The latest news and updates relating to Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma

• FingerMotion has maintained consistency in managing and communicating information to the public and investors throughout 2021
• So far, it has held announcements covering its qualification to trade on the OTCQX Best Market, financial results updates, collaborations with other companies, and any upcoming conferences
• In line with maintaining this momentum, the company is set to host a corporate update call on August 25, 2021
• The event, which is scheduled for 1:00 p.m. Eastern Time, will cover the company’s latest quarterly financial results, plans for an upcoming annual stockholders meeting, and the company’s application to have its shares listed on the Nasdaq Capital Market

Since it went public, FingerMotion (OTCQX: FNGR) has remained consistent and committed to managing and communicating information to the public. The company has always been upfront with its operations, financial standing, and managerial organization, a move that has allowed it to fulfill its mandate and appeal to a broader pool of potential investors. On August 25, 2021, the company will host a corporate update call in line with its investor relations rulebook (https://ibn.fm/DaDCu). The event, which will take place virtually at 1:00 p.m. Eastern Time, will be led by Martin Shen, the company’s Chief Executive Officer (“CEO”). He will cover various subjects including, but not limited to the company’s latest quarterly financial results, the plans for an upcoming annual meeting of stockholders, and the company’s application to have its shares listed on the Nasdaq Capital Market. This call will also be followed by a question and answer session where queries submitted via email will be answered by company representatives. FingerMotion has always made it a point to communicate all developments within the company. The first press release of the year was OTC Markets Group Inc.’s announcement that FingerMotion had qualified to trade on the OTCQX Best Market, an upgrade from the OTCQB Venture Market (https://ibn.fm/CglV4). Since then, the company has provided updates on financial results and agreements with companies such as Pacific Life Re, China Mobile Fujian, and Xunlian Tianxia Technology. FingerMotion has also been keen to announce upcoming conferences, along with applications to list its common stocks on the Nasdaq capital market. FingerMotion is an evolving technology company with critical competencies in mobile payment and recharge platform solutions. It focuses on the Chinese market and remains committed to developing additional value-added technologies to market to users. Its current product offerings include Big Data Insights, Rich Communication Services (“RCS”), SMS and MMS services, and Telecommunication Products and Services. With its August 25, 2021, corporate update call, FingerMotion would be keeping the momentum it has had throughout 2021 with its investor relations. Given its track record thus far, it is also safe to say that the public should expect more press releases, conference update calls, and further announcements from the company as time progresses. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• NexTech announced its financials for Q2 of the 2021 financial year, showing revenue totaling $6.1 million, a 73% year-over-year increase from the same period in 2020
• Gross profit also grew from $2.2 million in Q2 2020 to $2.3 million in Q2 2021, representing a 6% growth
• NexTech attributes improvement in performance to a more self-serve, highly scalable business model, better able to take advantage of the growing augmented reality industry

On August 12, 2021, NexTech AR Solutions (CSE: NTAR) (OTCQB: NEXCF) hosted a virtual conference discussing its results for the second quarter (“Q2”) 2021 fiscal year. Evan Gappelberg, the company’s Chief Executive Officer, and Andrew Chan, the Chief Financial Officer, discussed the company’s financial and operating results, followed by a live chat option where the audience asked questions later answered at the end of the event (https://ibn.fm/bAraC). Focus of the conference was on NexTech’s impressive performance over the three months that ended June 30, 2021. Revenue during that period totaled $6.1 million, a growth of over 73% compared to the same period in the 2020 fiscal year. Gross profit for this second quarter totaled $2.3 million, up from $2.2 million during the same period in 2020, representing a 6% increase. Total NexTech assets by June 30, 2021, amounted to $38.19 million, up from $29.08 million on December 31, 2020. On the other hand, total liabilities amounted to $5.53 million, down from $6.66 million on December 31, 2021. While making the announcement, Mr. Gappelberg noted: “In our Q2 2021 results, once again, we were reinforcing the importance of our three foundational pillars. We’re a leader in augmented reality technology underpinned by enabling digital transformation and growing our key verticals like education, entertainment, events, retail, medical and marketplaces, on LiveX. We are full steam ahead. I had total confidence in our plan, and in our team and the direction that our company is going.” NexTech is a leader in providing web-based augmented reality for e-commerce, virtual events and advertising. Its tech offerings range from simple 3D images to using 360-degree videos. The company can provide businesses with powerful end-to-end augmented reality platforms that guarantee online sales growth through this. NexTech attributed its Q2 2021 growth in performance to its shift to a more self-serve, highly scalable business model. Some of the development work therein, Mr. Gappelberg noted, is projected to be complete in early Q4, 2021 (https://ibn.fm/AM8lD). The company also announced its acquisition of Threedy.ai Inc., an AI-based end-to-end platform useful in producing 3D augmented reality models. It hopes that the use of this tech would accelerate its delivery time to customers, ultimately increasing customer satisfaction. NexTech is also set to acquire ARway in a move to grow its augmented reality solutions for its customers. The company projects that moving forward into Q3 and Q4, it will build on the outstanding performance posted in Q2. More specifically, Mr. Gappelberg reckoned that the company is now seeing a reacceleration in its tech services business, which will be a significant revenue stream going forward. With the current acquisitions and an increase in orders from clients such as Ryerson, Northwell Health, and Northeastern HMO, NexTech is confident that it has positioned itself to take advantage of the growing augmented reality industry. To listen to the entire conference call, please visit https://ibn.fm/AM8lD For more information, visit the company’s website at www.NextechAR.com. NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

• Le Pragma features a full retail offering of high-end, all-natural health, wellness and beauty products
• GTVH has strategy to push sales, strengthen products and launch business directly into international markets after acquisition
• Le Pragma will leverage key relationships, strategic partnerships forged by Sonder Fulfillment to expand globally

With a plan in place for global growth in the CBD space, Golden Triangle Ventures (OTC: GTVH) has signed a letter of intent to acquire Le Pragma LLC, a trusted product line with a focus on quality and consistent results (https://ibn.fm/CVk1p). Le Pragma features a full retail offering of high-end, all-natural health, wellness and beauty products. Leveraging the resources and expertise of Sonder Fulfillment, its wholly owned subsidiary, Golden Triangle plans to help Le Pragma achieve its strategic vision of becoming the CBD line of the future. “Our team has worked very hard to formalize a strong plan to push sales, strengthen the products involved and launch this business directly into the international markets after we formally acquire Le Pragma,” said Steffan Dalsgaard, GTVH CEO. “We look forward to officially bringing this business in under the GTV umbrella, and we are all confident that we have a stellar product with a direct plan to generate profits for our company.” From its inception, Le Pragma has had a commitment to quality and an end goal to provide luxurious cannabinoid products throughout the world, with each product created from cutting-edge formulations based on precise science. Le Pragma has also maintained a focus on education and worked tirelessly to provide consumers with clear, evidence-based information about the lifestyle benefits of cannabidiol, or CBD, and the products it offered. As part of that strategic vision, the company distinguished itself by creating an everyday-use regime formulated to activate the inner-cannabinoid system and bring out the beauty that lives beneath the toxins collected from everyday living. Currently, the Le Pragma product line includes high-quality CBD tinctures, wellness pills, pain cream, and lip balm, as well as a five-step CBD skincare system that includes a CBD face cleanser, exfoliant, serum, face oil and face cream. GTVH estimates that the valuation of all inventory acquired could generate more than $5 million in retail sales through established distribution channels. Le Pragma will leverage the global relationships and strategic partnerships forged by Sonder Fulfillment to enter international markets such as Macedonia, Mexico, and the Netherlands. “With the combination of an evidence-backed product line, the international relationships formed by Sonder Fulfillment and the resources provided by management, [Golden Triangle] is confident in its plan to grow Le Pragma into a global leader in the CBD industry and distribute its products worldwide,” the announcement stated. Golden Triangle Ventures is a multifaceted consulting company with many projects being developed that provide synergistic values in the health, entertainment and technology industries. The company aims to purchase, acquire and/or joint-venture with established entities that management can assist and develop into unique opportunities. Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business-development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. For more information, visit the company’s website at www.GoldenTriangleInc.com. NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://ibn.fm/GTVH

• So far in 2021, Mind Cure has embarked on an aggressive plan to strengthen its advisory board and file for new provisional patents for its fully synthetic ibogaine
• In January, the company also announced an amended agreement to grow the size of an earlier-announced bought deal financing
• This year has also seen the launch of the second stage of manufacturing of Ibogaine for use in psychedelic clinical research
• Mind Cure also continues to strengthen its proprietary digital therapeutics technology (“DTx”), iSTRYM
• All of Mind Cure’s decisions thus far are designed to help the company achieve overall growth and fulfill its vision of easing suffering, increasing productivity, and enhancing mental health

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) is regarded as a diversified life sciences company that is at the forefront of the mental health industry. The company’s current focus is on developing digital therapeutics, researching psychedelic compounds, and innovating and commercializing new ways to improve and promote healing for individuals dealing with mental health challenges. In a move to grow its market presence and overall brand equity, Mind Cure has embarked on an aggressive plan, firstly with strengthening its advisory board and filing for new provisional patents for its fully synthetic line of products. So far, in 2021, the company has expanded its product line with the launch of the second stage manufacturing of Ibogaine (https://ibn.fm/Jield). Ibogaine is a psychoactive substance present naturally in the roots of the African iboga tree. The company is researching the substance’s potential to treat traumatic brain injury (“TBI”). In January 2021, Mind Cure ushered the new year by announcing an amended agreement with a syndicate of underwriters to grow the size of an earlier-announced bought deal financing. This was a big move for the company that saw a growth in its valuation, with the proceeds from the offering used to further its agenda for product research, development, and expansion (https://ibn.fm/QQM4Y). In August, Mind Cure announced the appointment of Jerry White into the company’s advisory board (https://ibn.fm/TlNu4). For an individual recognized globally for his efforts in engaging large audiences to power global movements and a co-recipient of the 1997 Nobel Peace Prize, this was a big move for Mind Cure. More so, the company projected that with Mr. White’s addition to the board, it would be well-positioned to achieve bigger and better goals, all while working towards its overall vision of building mental wealth globally. Mind Cure also continues to strengthen its proprietary technology. Its artificial intelligence (“AI”) driven software platform, iSTRYM, is set to enable personalized and quantified outcomes in psychedelic-assisted therapy, with the company projecting a minimal viable product (“MVP”) of the software by the third quarter (“Q3”) of the 2021 fiscal year. Digital therapeutics (“DTx”) continue to leverage smart devices to induce behavioral changes among patients (https://ibn.fm/JGfUh). 2021 has, so far, been good for Mind Cure. The company continues to push the envelope in research, technology, management, and overall approach towards the mental health market. Everything that the company has done so far is geared towards achieving overall growth and fulfilling its vision of easing suffering, increasing productivity, and enhancing mental health. As such, the company is very optimistic about the future. For more information, visit the company’s website at www.MindCure.com. NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF

• Flora Growth Corp. is a global cannabis production and distribution company that has created a premium house of brands which supplying its cannabis products for cosmetics, pharmaceuticals, natural wellness, hemp textiles, and food and beverages, with high-quality product at below-standard costs
• Flora Growth’s primary regulatory licensed operations are in Colombia, where the country’s government recently pursued a new openness in cannabis exports and domestic regulation by lifting bans on the sale and export of dried flower and cannabinoid ingestible products, permitting the sale of custom formulas for medical cannabis, and loosened marketing restrictions
• Flora Growth has been actively involved in M&A activity, the latest being an announced LOI to acquire 100 percent of luxury cannabis accessories producer Vessel Brand
• The company held an earnings call with investors on August 19 to discuss its first half financial results, provide operational updates, and M&A initiatives
• Flora Growth participated the same day in the SNN Network Summer Virtual Event, presenting information on the company’s activities to a variety of global investors

Global cannabis cultivator and product distributor Flora Growth (NASDAQ: FLGC) is increasing awareness of its position within the international marketplace as well as recent agreements expected to boost its revenues. The company presented information about its operations to investors during the SNN Network Summer Virtual Event on August 19, followed by an earnings call for the first half of the 2021 fiscal year held the same day. Flora Growth is an internationally focused cannabis consumer packaged goods company that is headquartered in Canada, planning to move its offices to Miami, Florida in the United States at the beginning of next year, and is running its cultivation and processing operations in Colombia while anticipating a significant end user market in the EU, Australia and throughout Latin America. Colombia has been developing its cannabis industry following years of internal and external strife over illegal drug production in a country with nearly ideal growing conditions for the leafy green plant that has thrown off much of its stigma during the past decade and is now being developed for therapeutic uses in a number of countries. Last month, Colombian President Ivan Duque lifted a ban on exporting dried cannabis flower, which is generating excitement among investors (https://ibn.fm/rzLYN). Flora Growth’s expansive land package with unique onsite natural resources, use of a skilled workforce, and familiarity with Colombia’s legal machinery (Juan Manuel Galán Pachon, a former Colombian senator and the author of the Colombian medical cannabis law, sits on Flora’s board of strategic advisors) are giving it an advantage at a crucial point in history. Colombia had begun allowing dried cannabis to be exported as medicinal oils or extracts, but the new decree allows growers to supply cannabis raw materials for use in a variety of different market segments on the international stage, while also enhancing accessibility to a much more robust domestic and regional market. At the August 19 SNN Network Summer Virtual Event, Flora Growth was among 60 small cap, micro cap and nano cap companies participating in webcast presentations to investors on the global stage over the course of three days (https://ibn.fm/HQM1N). Flora Growth’s presentation was scheduled at 2:30 p.m. EDT, with the investor call following at 4:30 p.m. EDT. (https://ibn.fm/QM5wd). The investor call included financial results, operational updates, and executive commentary on the company’s recent growth and on M&A initiatives that have been announced since Flora Growth’s Nasdaq Capital Market listing in May, followed by a Q&A. The latest planned acquisition was announced Aug. 17, when Flora Growth’s management released news that the company has signed an LOI to acquire 100 percent of Vessel Brand Inc., a California company with a “lineup of high-end dry-herb accessories and vape pen batteries, bespoke product programs for brands, and decades of go-to-market experience,” according to the announcement (https://ibn.fm/FNuVe). “Our mission is to deliver value for our shareholders through the manufacturing and sale of premium cannabis brands and products, and we believe that the best way to achieve that goal is to operate responsibly and sustainably,” Dr. Annabelle Manalo-Morgan, Director and Lead Scientific Advisor of Flora, stated in another company news release (https://ibn.fm/tnCJL). The financial call webcast will be archived and available on the company’s website. For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• Company signed agreement with Premier Distribution Services to distribute entire Alkaline88(R) bottled water line
• PDS network includes more than 800 gyms, sports nutrition stores, personal training studios and smoothie bars
• “Great partnership for both parties,” says WTER CEO

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) continues its pattern of steady success with its most recent distribution announcement: the company has signed an agreement with Premier Distribution Services (“PDS”) to distribute WTER’s entire Alkaline88(R) bottled water line to more than 800 gyms, sports nutrition stores, personal training studios and smoothie bars (https://ibn.fm/DNdlg). The company, now sitting atop the list of the largest independent alkaline water companies in the country, has seen consistent growth for the past seven quarters. “This is a wonderful opportunity for the company as Premier Distribution Services will be carrying all of our Alkaline88 bottled waters in coolers across the country,” said Ricky Wright, president and CEO of The Alkaline Water Company. “It will help us introduce and drive the trial of our new 2-liter, aluminum and flavor-infused SKUs. It will also allow for the chilled on-premise purchase of the country’s favorite premium gallon water, Alkaline88. This is a great partnership for both parties. PDS’s clients will be able to offer health-conscious gym-goers the Smooth Hydration(TM) of Alkaline88, the Clean Beverage(TM). While PDS continues to execute their growth plan, we’ll expand with them in health and fitness venues across the country.” With distribution centers in Florida, Nevada and Texas, PDS is preparing to open new centers in the South and Midwest. The company’s short-term strategic plan is projected to more than double its existing locations before the end of the year. The growth that WTER anticipates from its PDS partnership aligns nicely with the increased brand awareness and product demand the company expects to see as it rolls out its newest marketing campaign. “As we plan to mobilize our first broadly distributed traditional marketing campaign with Shaquille O’Neal later this year, more and more people will be looking for our brand as their go-to choice to rehydrate during their workouts,” said Wright. “The timing couldn’t be any better.” Basketball Hall of Famer and entertainment icon O’Neil joined the company earlier this year as an equity partner and board member; he also serves as a marquee brand ambassador for Alkaline88 (https://ibn.fm/w5w3b). “Shaquille O’Neal’s track record as a basketball champion and Hall of Famer has translated into similar successes in business and corporate partnerships. His reputation as an astute investor, larger-than-life brand partner, and phenomenal ambassador makes this partnership extremely exciting,” said WTER chairman Aaron Keay. “We want to welcome Shaquille to the company’s advisory board and believe his positive presence and global outreach will enable Alkaline88 to aggressively push our growth trajectory even faster.” Alkaline88 is known for its superior hydration with a perfect 8.8pH balance. The brand was developed to deliver a smooth taste that encourages consumers to drink more and fully hydrate, and the company is dedicated to purity, quality, and value. The water’s ingredient deck is simple, easy to understand, and free of buffers. Dubbed “the clean beverage,” Alkaline88 ionized water contains just two pure ingredients that customers trust — water and Pink Himalayan Rock Salt. For more information, visit the company’s websites at www.TheAlkalineWaterCo.com and www.a88CBD.com. NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER